Details for 2013835019
Up to date per 02.04.2026
Actions
Details for 2013835019
Granted/Registered
European Patent
15.07.2015 A
22.09.2021 B1
04.09.2012
US
201261696375 P
A61K 31/519 20060101AFI20160304BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
LAQUERRE, Sylviec/o GlaxoSmithKline Global Patents Department 709 Swedeland Road King of Prussia, Pennsylvania 19406US
LEBOWITZ, Peter F.c/o GlaxoSmithKline Global Patents Department Five Moore Drive P. O. Box 13398 Research Triangle Park, North Carolina 27709US
Information about Fees